The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion...

Published on 5 Aug 2023 on American City Business Journals

Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYCN),...

Read the rest of the article

Start tracking your investments with Statfolio

As investors navigate a mixed market landscape, with major indices showing varied performances am...

Simply Wall St. · via Yahoo Finance 2 Feb 2025

As U.S. stocks experience fluctuations amid anticipation of key inflation data and interest rate ...

Simply Wall St. · via Yahoo Finance 10 Dec 2024

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip ou...

Insider Monkey via Yahoo Finance 24 Mar 2024

Insiders who bought US$1.95m worth of Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN) stock at an av...

Simply Wall St. via Yahoo Finance 29 Nov 2023

Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYC...

American City Business Journals 5 Aug 2023

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (form...

Benzinga via Yahoo Finance 12 May 2023

GreenLight Biosciences Holdings Inc. is laying off a quarter of its staff eight months after it w...

American City Business Journals 27 Oct 2022

Cyclerion Therapeutics Inc. is culling its workforce as it narrows its focus to mitochondrial...

American City Business Journals 7 Oct 2022

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.15%

Investing.com 6 Oct 2022

Cyclerion Therapeutics Inc (NASDAQ: CYCN) is reprioritizing development programs and focusing res...

Benzinga via Yahoo Finance 6 Oct 2022